Skip to content

Opening book details…

About this Medicine article

SO-4 phase Ib/II, open-label, randomised evaluation of atezolizumab plus RO6874281 vs control in MORPHEUS–pancreatic ductal adenocarcinoma by Chung, V.; Alistar, A.; George, B.; Kim, K.; Kindler, H.; Oh, D.; Allen, S.; Barak, H.; Ci, B.; Lau, J.; Retiere, A.; Shemesh, C.; Teichgräber, V.; Zhang, X.; Lopez, C. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Chung, V.; Alistar, A.; George, B.; Kim, K.; Kindler, H.; Oh, D.; Allen, S.; Barak, H.; Ci, B.; Lau, J.; Retiere, A.; Shemesh, C.; Teichgräber, V.; Zhang, X.; Lopez, C.
Publisher
Oxford University Press; Elsevier BV (ISSN 0923-7534)
Published
2020
Field
Medicine (Health Sciences)

More by Chung, V.; Alistar, A.; George, B.; Kim, K.; Kindler, H.; Oh, D.; Allen, S.; Barak, H.; Ci, B.; Lau, J.; Retiere, A.; Shemesh, C.; Teichgräber, V.; Zhang, X.; Lopez, C.

Browse all works by Chung, V.; Alistar, A.; George, B.; Kim, K.; Kindler, H.; Oh, D.; Allen, S.; Barak, H.; Ci, B.; Lau, J.; Retiere, A.; Shemesh, C.; Teichgräber, V.; Zhang, X.; Lopez, C.